<SEC-DOCUMENT>0001104659-20-095518.txt : 20200814
<SEC-HEADER>0001104659-20-095518.hdr.sgml : 20200814
<ACCEPTANCE-DATETIME>20200814160840
ACCESSION NUMBER:		0001104659-20-095518
CONFORMED SUBMISSION TYPE:	13F-HR
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200630
FILED AS OF DATE:		20200814
DATE AS OF CHANGE:		20200814
EFFECTIVENESS DATE:		20200814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAKER BROS. ADVISORS LP
		CENTRAL INDEX KEY:			0001263508
		IRS NUMBER:				134093645
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		13F-HR
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	028-10519
		FILM NUMBER:		201105092

	BUSINESS ADDRESS:	
		STREET 1:		860 WASHINGTON STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014
		BUSINESS PHONE:		2123395600

	MAIL ADDRESS:	
		STREET 1:		860 WASHINGTON STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAKER BROS ADVISORS LLC
		DATE OF NAME CHANGE:	20030911
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>13F-HR</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags>
        <confirmingCopyFlag>false</confirmingCopyFlag>
        <returnCopyFlag>false</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
      <filer>
        <credentials>
          <cik>0001263508</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>06-30-2020</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>06-30-2020</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>BAKER BROS. ADVISORS LP</name>
        <address>
          <ns1:street1>860 WASHINGTON STREET</ns1:street1>
          <ns1:street2>3RD FLOOR</ns1:street2>
          <ns1:city>NEW YORK</ns1:city>
          <ns1:stateOrCountry>NY</ns1:stateOrCountry>
          <ns1:zipCode>10014</ns1:zipCode>
        </address>
      </filingManager>
      <reportType>13F HOLDINGS REPORT</reportType>
      <form13FFileNumber>028-10519</form13FFileNumber>
      <provideInfoForInstruction5>N</provideInfoForInstruction5>
    </coverPage>
    <signatureBlock>
      <name>Alexandra Toohey</name>
      <title>Chief Financial Officer</title>
      <phone>212-339-5690</phone>
      <signature>/s/ Alexandra Toohey</signature>
      <city>New York</city>
      <stateOrCountry>NY</stateOrCountry>
      <signatureDate>08-14-2020</signatureDate>
    </signatureBlock>
    <summaryPage>
      <otherIncludedManagersCount>0</otherIncludedManagersCount>
      <tableEntryTotal>114</tableEntryTotal>
      <tableValueTotal>22670991</tableValueTotal>
    </summaryPage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>infotable.xml
<TEXT>
<XML>
<?xml version="1.0" ?>
<informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <infoTable>
    <nameOfIssuer>Abeona Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00289Y107</cusip>
    <value>4637</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1590686</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1590686</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ACADIA Pharmaceuticals Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>004225108</cusip>
    <value>2031115</value>
    <shrsOrPrnAmt>
      <sshPrnamt>41904586</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>41904586</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Acceleron Pharma Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00434H108</cusip>
    <value>2572</value>
    <shrsOrPrnAmt>
      <sshPrnamt>27000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>27000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Adamas Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00548A106</cusip>
    <value>442</value>
    <shrsOrPrnAmt>
      <sshPrnamt>172630</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>172630</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Adaptive Biotechnologies Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00650F109</cusip>
    <value>22426</value>
    <shrsOrPrnAmt>
      <sshPrnamt>463539</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>463539</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Adaptimmune Therapeutics plc</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>00653A107</cusip>
    <value>66819</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6675181</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>6675181</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ADC Therapeutics SA</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>H0036K147</cusip>
    <value>78992</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1687500</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1687500</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Aeglea BioTherapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00773J103</cusip>
    <value>40511</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4379592</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4379592</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Affimed N.V.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>N01045108</cusip>
    <value>923</value>
    <shrsOrPrnAmt>
      <sshPrnamt>200000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>200000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Aimmune Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00900T107</cusip>
    <value>11261</value>
    <shrsOrPrnAmt>
      <sshPrnamt>673908</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>673908</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Albireo Pharma, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>01345P106</cusip>
    <value>9776</value>
    <shrsOrPrnAmt>
      <sshPrnamt>369047</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>369047</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Alector, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>014442107</cusip>
    <value>6843</value>
    <shrsOrPrnAmt>
      <sshPrnamt>280000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>280000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Alexion Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>015351109</cusip>
    <value>983312</value>
    <shrsOrPrnAmt>
      <sshPrnamt>8760794</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>8760794</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Alkermes plc</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>G01767105</cusip>
    <value>24154</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1244744</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1244744</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Allakos Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>01671P100</cusip>
    <value>52851</value>
    <shrsOrPrnAmt>
      <sshPrnamt>735469</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>735469</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Altimmune, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>02155H200</cusip>
    <value>22572</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2107600</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2107600</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Amarin Corporation plc</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>023111206</cusip>
    <value>238717</value>
    <shrsOrPrnAmt>
      <sshPrnamt>34496685</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>34496685</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>AnaptysBio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>032724106</cusip>
    <value>11476</value>
    <shrsOrPrnAmt>
      <sshPrnamt>513677</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>513677</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Apellis Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>03753U106</cusip>
    <value>29281</value>
    <shrsOrPrnAmt>
      <sshPrnamt>896551</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>896551</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Applied Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>03828A101</cusip>
    <value>2384</value>
    <shrsOrPrnAmt>
      <sshPrnamt>65934</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>65934</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Aravive, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>03890D108</cusip>
    <value>2841</value>
    <shrsOrPrnAmt>
      <sshPrnamt>244055</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>244055</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Arcus Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>03969F109</cusip>
    <value>3007</value>
    <shrsOrPrnAmt>
      <sshPrnamt>121534</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>121534</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>argenx SE</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>04016X101</cusip>
    <value>229635</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1019557</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1019557</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ARYA Sciences Acquisition Corp.</nameOfIssuer>
    <titleOfClass>SHS CL A</titleOfClass>
    <cusip>G3165V109</cusip>
    <value>2361</value>
    <shrsOrPrnAmt>
      <sshPrnamt>150000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>150000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Ascendis Pharma A/S</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>04351P101</cusip>
    <value>501421</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3390270</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3390270</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Assembly Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>045396108</cusip>
    <value>35951</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1541618</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1541618</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Atreca, Inc.</nameOfIssuer>
    <titleOfClass>CL A COM</titleOfClass>
    <cusip>04965G109</cusip>
    <value>75177</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3532760</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3532760</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Aurinia Pharmaceuticals Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>05156V102</cusip>
    <value>27656</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1701929</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1701929</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Autolus Therapeutics plc</nameOfIssuer>
    <titleOfClass>SPON ADS</titleOfClass>
    <cusip>05280R100</cusip>
    <value>7785</value>
    <shrsOrPrnAmt>
      <sshPrnamt>485624</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>485624</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Axsome Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>05464T104</cusip>
    <value>83083</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1009757</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1009757</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BeiGene, Ltd.</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>07725L102</cusip>
    <value>2218840</value>
    <shrsOrPrnAmt>
      <sshPrnamt>11777285</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>11777285</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Bellicum Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>079481404</cusip>
    <value>1851</value>
    <shrsOrPrnAmt>
      <sshPrnamt>249123</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>249123</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BioCryst Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>09058V103</cusip>
    <value>65597</value>
    <shrsOrPrnAmt>
      <sshPrnamt>13766405</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>13766405</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BioMarin Pharmaceutical Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>09061G101</cusip>
    <value>936064</value>
    <shrsOrPrnAmt>
      <sshPrnamt>7589294</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>7589294</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>bluebird bio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>09609G100</cusip>
    <value>16176</value>
    <shrsOrPrnAmt>
      <sshPrnamt>265000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>265000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Burning Rock Biotech Limited</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>12233L107</cusip>
    <value>6753</value>
    <shrsOrPrnAmt>
      <sshPrnamt>250000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>250000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Cabaletta Bio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>12674W109</cusip>
    <value>7089</value>
    <shrsOrPrnAmt>
      <sshPrnamt>636363</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>636363</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Catalyst Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>14888U101</cusip>
    <value>2310</value>
    <shrsOrPrnAmt>
      <sshPrnamt>500000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>500000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Cerus Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>157085101</cusip>
    <value>90507</value>
    <shrsOrPrnAmt>
      <sshPrnamt>13713195</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>13713195</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ChemoCentryx, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>16383L106</cusip>
    <value>54388</value>
    <shrsOrPrnAmt>
      <sshPrnamt>945221</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>945221</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Chiasma, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>16706W102</cusip>
    <value>5093</value>
    <shrsOrPrnAmt>
      <sshPrnamt>946701</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>946701</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Constellation Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>210373106</cusip>
    <value>4007</value>
    <shrsOrPrnAmt>
      <sshPrnamt>133333</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>133333</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Crinetics Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>22663K107</cusip>
    <value>5569</value>
    <shrsOrPrnAmt>
      <sshPrnamt>317857</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>317857</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CymaBay Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>23257D103</cusip>
    <value>5315</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1522792</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1522792</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>DBV Technologies S.A.</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>23306J101</cusip>
    <value>64157</value>
    <shrsOrPrnAmt>
      <sshPrnamt>14614264</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>14614264</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Denali Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>24823R105</cusip>
    <value>2536</value>
    <shrsOrPrnAmt>
      <sshPrnamt>104900</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>104900</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Dicerna Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>253031108</cusip>
    <value>3031</value>
    <shrsOrPrnAmt>
      <sshPrnamt>119335</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>119335</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Exact Sciences Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>30063P105</cusip>
    <value>160503</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1846139</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1846139</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Evofem Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>30048L104</cusip>
    <value>4033</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1425000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1425000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Frequency Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>35803L108</cusip>
    <value>21988</value>
    <shrsOrPrnAmt>
      <sshPrnamt>945719</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>945719</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Forma Therapeutics Holdings, Inc.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>34633R104</cusip>
    <value>92980</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2000000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2000000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Fulgent Genetics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>359664109</cusip>
    <value>9111</value>
    <shrsOrPrnAmt>
      <sshPrnamt>569444</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>569444</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Galapagos NV</nameOfIssuer>
    <titleOfClass>SPON ADR</titleOfClass>
    <cusip>36315X101</cusip>
    <value>2579</value>
    <shrsOrPrnAmt>
      <sshPrnamt>13072</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>13072</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Galmed Pharmaceuticals Ltd.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>M47238106</cusip>
    <value>1031</value>
    <shrsOrPrnAmt>
      <sshPrnamt>215594</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>215594</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Gamida Cell Ltd.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>M47364100</cusip>
    <value>3047</value>
    <shrsOrPrnAmt>
      <sshPrnamt>666666</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>666666</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Genfit SA</nameOfIssuer>
    <titleOfClass>ADS</titleOfClass>
    <cusip>372279109</cusip>
    <value>156</value>
    <shrsOrPrnAmt>
      <sshPrnamt>28396</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>28396</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Global Blood Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>37890U108</cusip>
    <value>2967</value>
    <shrsOrPrnAmt>
      <sshPrnamt>47000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>47000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>GW Pharmaceuticals plc</nameOfIssuer>
    <titleOfClass>ADS</titleOfClass>
    <cusip>36197T103</cusip>
    <value>22709</value>
    <shrsOrPrnAmt>
      <sshPrnamt>185045</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>185045</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Heron Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>427746102</cusip>
    <value>88526</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6018104</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>6018104</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>HOOKIPA Pharma Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>43906K100</cusip>
    <value>8140</value>
    <shrsOrPrnAmt>
      <sshPrnamt>700481</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>700481</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Horizon Therapeutics Public Ltd Co</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>G46188101</cusip>
    <value>11116</value>
    <shrsOrPrnAmt>
      <sshPrnamt>200000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>200000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Idera Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM PAR</titleOfClass>
    <cusip>45168K405</cusip>
    <value>8250</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4608786</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4608786</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>IGM Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>449585108</cusip>
    <value>229528</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3144223</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3144223</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Immunomedics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>452907108</cusip>
    <value>11695</value>
    <shrsOrPrnAmt>
      <sshPrnamt>330000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>330000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Incyte Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45337C102</cusip>
    <value>3326944</value>
    <shrsOrPrnAmt>
      <sshPrnamt>31999081</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>31999081</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Infinity Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45665G303</cusip>
    <value>525</value>
    <shrsOrPrnAmt>
      <sshPrnamt>580400</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>580400</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Inflarx N.V.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>N44821101</cusip>
    <value>4859</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1058555</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1058555</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Insmed Incorporated</nameOfIssuer>
    <titleOfClass>COM PAR $.01</titleOfClass>
    <cusip>457669307</cusip>
    <value>83319</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3025384</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3025384</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Intellia Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45826J105</cusip>
    <value>2702</value>
    <shrsOrPrnAmt>
      <sshPrnamt>128538</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>128538</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Invitae Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>46185L103</cusip>
    <value>358966</value>
    <shrsOrPrnAmt>
      <sshPrnamt>11850962</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>11850962</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>IVERIC bio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>46583P102</cusip>
    <value>8341</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1635501</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1635501</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Karuna Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>48576A100</cusip>
    <value>9137</value>
    <shrsOrPrnAmt>
      <sshPrnamt>81976</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>81976</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kezar Life Sciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>49372L100</cusip>
    <value>3108</value>
    <shrsOrPrnAmt>
      <sshPrnamt>600000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>600000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kiniksa Pharmaceuticals, Ltd.</nameOfIssuer>
    <titleOfClass>COM CL A</titleOfClass>
    <cusip>G5269C101</cusip>
    <value>71333</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2799577</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2799577</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kodiak Sciences Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>50015M109</cusip>
    <value>626414</value>
    <shrsOrPrnAmt>
      <sshPrnamt>11574538</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>11574538</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Krystal Biotech, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>501147102</cusip>
    <value>33866</value>
    <shrsOrPrnAmt>
      <sshPrnamt>817631</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>817631</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Leap Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>52187K101</cusip>
    <value>2045</value>
    <shrsOrPrnAmt>
      <sshPrnamt>978454</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>978454</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Legend Biotech Corporation</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>52490G102</cusip>
    <value>5746</value>
    <shrsOrPrnAmt>
      <sshPrnamt>135000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>135000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Madrigal Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>558868105</cusip>
    <value>169786</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1499212</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1499212</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Marker Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>57055L107</cusip>
    <value>498</value>
    <shrsOrPrnAmt>
      <sshPrnamt>240505</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>240505</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Matinas BioPharma Holdings, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>576810105</cusip>
    <value>1620</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2096375</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2096375</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Merus N.V.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>N5749R100</cusip>
    <value>32783</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2037469</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2037469</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Mirati Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>60468T105</cusip>
    <value>160955</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1409784</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1409784</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Mirum Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>604749101</cusip>
    <value>11352</value>
    <shrsOrPrnAmt>
      <sshPrnamt>583333</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>583333</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Molecular Templates, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>608550109</cusip>
    <value>2182</value>
    <shrsOrPrnAmt>
      <sshPrnamt>158217</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>158217</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>MyoKardia, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>62857M105</cusip>
    <value>305728</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3164234</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3164234</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neoleukin Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>64049K104</cusip>
    <value>56402</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3397740</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3397740</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neurocrine Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>64125C109</cusip>
    <value>110652</value>
    <shrsOrPrnAmt>
      <sshPrnamt>906986</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>906986</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>NGM Biopharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>62921N105</cusip>
    <value>2456</value>
    <shrsOrPrnAmt>
      <sshPrnamt>124400</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>124400</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Novavax, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>670002401</cusip>
    <value>20119</value>
    <shrsOrPrnAmt>
      <sshPrnamt>241376</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>241376</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Orchard Therapeutics plc</nameOfIssuer>
    <titleOfClass>ADS</titleOfClass>
    <cusip>68570P101</cusip>
    <value>2434</value>
    <shrsOrPrnAmt>
      <sshPrnamt>405702</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>405702</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Ovid Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>690469101</cusip>
    <value>3377</value>
    <shrsOrPrnAmt>
      <sshPrnamt>458253</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>458253</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Oyster Point Pharma, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>69242L106</cusip>
    <value>2063</value>
    <shrsOrPrnAmt>
      <sshPrnamt>71428</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>71428</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Passage Bio, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>702712100</cusip>
    <value>7516</value>
    <shrsOrPrnAmt>
      <sshPrnamt>275000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>275000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Principia Biopharma Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74257L108</cusip>
    <value>94520</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1580873</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1580873</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Protagonist Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74366E102</cusip>
    <value>33756</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1911446</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1911446</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Protara Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM STK</titleOfClass>
    <cusip>74365U107</cusip>
    <value>5854</value>
    <shrsOrPrnAmt>
      <sshPrnamt>199671</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>199671</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Reata Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>CL A</titleOfClass>
    <cusip>75615P103</cusip>
    <value>8734</value>
    <shrsOrPrnAmt>
      <sshPrnamt>55983</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>55983</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Replimune Group, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>76029N106</cusip>
    <value>128</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5141</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>5141</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rhythm Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>76243J105</cusip>
    <value>60211</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2700055</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2700055</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sangamo Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>800677106</cusip>
    <value>8958</value>
    <shrsOrPrnAmt>
      <sshPrnamt>999823</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>999823</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Seattle Genetics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>812578102</cusip>
    <value>8032021</value>
    <shrsOrPrnAmt>
      <sshPrnamt>47269424</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>47269424</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sunesis Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>867328700</cusip>
    <value>147</value>
    <shrsOrPrnAmt>
      <sshPrnamt>556665</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>556665</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Syros Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>87184Q107</cusip>
    <value>7357</value>
    <shrsOrPrnAmt>
      <sshPrnamt>690167</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>690167</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Tricida, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>89610F101</cusip>
    <value>21643</value>
    <shrsOrPrnAmt>
      <sshPrnamt>787582</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>787582</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>uniQure N.V.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>N90064101</cusip>
    <value>10404</value>
    <shrsOrPrnAmt>
      <sshPrnamt>230883</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>230883</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Urovant Sciences Ltd.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>G9381B108</cusip>
    <value>9840</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1000000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1000000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Vaxart, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92243A200</cusip>
    <value>14506</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1639121</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1639121</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Viking Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92686J106</cusip>
    <value>3064</value>
    <shrsOrPrnAmt>
      <sshPrnamt>425000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>425000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Xencor, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98401F105</cusip>
    <value>13867</value>
    <shrsOrPrnAmt>
      <sshPrnamt>428120</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>428120</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Xenon Pharmaceuticals Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98420N105</cusip>
    <value>10021</value>
    <shrsOrPrnAmt>
      <sshPrnamt>799102</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>799102</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Zymeworks Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98985W102</cusip>
    <value>61625</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1708472</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1708472</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BioMarin Pharmaceutical Inc.</nameOfIssuer>
    <titleOfClass>NOTE 0.599% 8/1/2024</titleOfClass>
    <cusip>09061GAH4</cusip>
    <value>18340</value>
    <shrsOrPrnAmt>
      <sshPrnamt>15000000</sshPrnamt>
      <sshPrnamtType>PRN</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>15000000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neurocrine Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>NOTE 2.25% 5/15/2024</titleOfClass>
    <cusip>64125CAD1</cusip>
    <value>51144</value>
    <shrsOrPrnAmt>
      <sshPrnamt>30770000</sshPrnamt>
      <sshPrnamtType>PRN</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>30770000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
</informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
